Drug Type Small molecule drug |
Synonyms Calcium citrate/Magnesium carbonate, OsvaRen, Rephoren |
Target |
Mechanism Phosphates modulators(Phosphates modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date DE (01 Jul 2006), |
Regulation- |
Molecular FormulaC6H12CaMg2O10 |
InChIKeyBAWGBFZDYGEMLQ-UHFFFAOYSA-N |
CAS Registry1173882-48-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hyperphosphatemia | DE | 01 Jul 2006 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Kidney Diseases | Phase 3 | DE | 01 Jan 2014 |
Not Applicable | - | - | Mg salts (Mg carbonate and Ca acetate, Osvaren) | ccvowibcmz(myujtvdljb) = rjoxzfivdd ijtvwcfudr (htjicfygmp ) | Positive | 30 Oct 2012 | |
Lanthane Carbonate (Fosrenol) | ccvowibcmz(myujtvdljb) = afsyejilxw ijtvwcfudr (htjicfygmp ) |